VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching

Phase 4

Terminated

Conditions: Pruritus

Interventions: Drug: Placebo or sugar pill
Drug: Cetirizine

First Posted Date: 2013-04-05

Last Posted Date: 2018-10-10

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 3

Registration Number: NCT01825655

Locations: 🇺🇸
Children's Hospital of Richmond at VCU, Richmond, Virginia, United States

Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma

Phase 2

Completed

Conditions: Recurrent Adult Brain Neoplasm
Glioblastoma
Malignant Glioma
WHO Grade III Glioma

Interventions: Drug: sorafenib tosylate
Drug: valproic acid
Drug: sildenafil citrate

First Posted Date: 2013-03-25

Last Posted Date: 2024-07-17

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 47

Registration Number: NCT01817751

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Exercise Training in Depressed Traumatic Brain Injury Survivors

Not Applicable

Withdrawn

Conditions: Depression
Traumatic Brain Injury

Interventions: Other: stretching and flexibility program
Other: aerobic exercise

First Posted Date: 2013-03-06

Last Posted Date: 2015-12-21

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT01805479

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Compassionate Same-Day Evaluation & Delivery of XRT for Bony Metastasis in Hospice Patients

Not Applicable

Terminated

Conditions: Symptomatic Osseous Bone Lesions From Any Malignancy

Interventions: Radiation: Radiation Therapy
Other: Quality-of-Life Assessment
Other: Survey Administration

First Posted Date: 2013-01-04

Last Posted Date: 2016-02-29

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 1

Registration Number: NCT01760941

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer

Not Applicable

Terminated

Conditions: Prostate Adenocarcinoma
Stage I Prostate Cancer

Interventions: Radiation: stereotactic body radiation therapy
Radiation: four fraction split-course SBRT

First Posted Date: 2012-11-29

Last Posted Date: 2019-09-03

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 19

Registration Number: NCT01737151

Locations: 🇺🇸
University of Virginia Medical Center, Charlottesville, Virginia, United States
🇺🇸
Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States
🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD)

Phase 1

Completed

Conditions: Gastrointestinal Bleeding

Interventions: Drug: Octreotide LAR Depot

First Posted Date: 2012-10-16

Last Posted Date: 2017-02-03

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 10

Registration Number: NCT01707225

Locations: 🇺🇸
Virginia Commonwealth University Health System, Richmond, Virginia, United States

International Plastic Bronchitis Registry

Terminated

Conditions: Plastic Bronchitis

First Posted Date: 2012-08-14

Last Posted Date: 2020-03-11

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 23

Registration Number: NCT01663948

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

The Effect of Humidification on Mucus Rheology

Completed

Conditions: Chronic Obstructive Pulmonary Disease(COPD)

First Posted Date: 2012-08-09

Last Posted Date: 2014-12-10

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 18

Registration Number: NCT01661374

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease

Not Applicable

Completed

Conditions: Mild Cognitive Impairment
Parkinson's Disease

Interventions: Behavioral: Supportive Therapy
Behavioral: Memory and Problem-Solving Intervention

First Posted Date: 2012-07-20

Last Posted Date: 2016-01-08

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 32

Registration Number: NCT01646333

Locations: 🇺🇸
VCU Parkinson's and Movement Disorders Center, Richmond, Virginia, United States

Biomarkers of Ischemia: Xanthine, Hypoxanthine and Inosine Levels During Carotid Stenting Procedures

Completed

Conditions: Ischemia/Hypoperfusion of Brain
Identify the Presence of a Marker of Ischemia/Hypoperfusion of the Brain Via Peripheral Blood

First Posted Date: 2012-07-12

Last Posted Date: 2018-07-31

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 10

Registration Number: NCT01639534

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy